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Abstract 
Background: In intensive care units (ICUs) treating patients with Coronavirus disease 2019 (COVID-19) invasive venti-
lation poses a high risk for aerosol and droplet formation. Surface contamination of severe acute respiratory syndrome 
Coronavirus 2 (SARS-CoV-2) or bacteria can result in nosocomial transmission.
Methods: Two tertiary care COVID-19 intensive care units treating 53 patients for 870 patient days were sampled 
after terminal cleaning and preparation for regular use to treat non-COVID-19 patients.
Results: A total of 176 swabs were sampled of defined locations covering both ICUs. No SARS-CoV-2 ribonucleic acid 
(RNA) was detected. Gram-negative bacterial contamination was mainly linked to sinks and siphons. Skin flora was 
isolated from most swabbed areas and Enterococcus faecium was detected on two keyboards.
Conclusions: After basic cleaning with standard disinfection measures no remaining SARS-CoV-2 RNA was detected. 
Bacterial contamination was low and mainly localised in sinks and siphons.
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Background
During the last months, the novel Coronavirus disease 
(COVID-19) pandemic has challenged many health-care 
systems worldwide. In line with the growing knowledge 
about specific pathophysiologic mechanisms, COVID-
19 has increasingly been associated with bacterial co-
infections, exhibiting high rates in intensive care units 
(ICUs) [1–4]. It is estimated that around 50% of fatalities 
associated with COVID-19 had secondary infections 
contributing to the disease course with a relevant impact 
on patient outcomes [5, 6]. Treating critically ill COVID-
19 patients often involves mechanical ventilation, which 
poses a high risk for droplet and aerosol transmission. In 
addition to the risk of severe acute respiratory syndrome 
Coronavirus 2 (SARS-CoV-2) contamination of surfaces 
and medical equipment, bacterial pathogens complicat-
ing the disease course can be transmitted to the environ-
ment surrounding the patient. Equipment and surfaces 
(e.g. respirators, beds) are well known for contributing to 
the transmission of bacterial pathogens promoting noso-
comial infections [7, 8].
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With the decline of the current COVID-19 outbreak in 
some countries, affected ICUs now returning to treating 
non-COVID-19 patients are being faced with the chal-
lenge of disinfecting their equipment and facilities in 
order to prevent hospital-acquired infections. Moreover, 
it is currently not well characterised whether or how long 
SARS-CoV-2 ribonucleic acid (RNA) persists on surfaces 
after complete disinfection of ICUs.
The aim of this study was to investigate the burden of 
pathogenic bacteria and SARS-CoV-2 RNA on different 
devices and surfaces after terminal cleaning measures 
in two specialised ICUs of a tertiary care hospital exclu-
sively treating COVID-19 patients.
Methods
Study setting
This single-blinded study was conducted at the Univer-
sity Hospital Zurich, Switzerland, a tertiary care hospital 
with around 980 beds. During the COVID-19 pandemic, 
two defined subunits of the ICU were designated to 
exclusively treat COVID-19 patients. The first (ICU 1) 
had the capacity to treat 16 patients, the second (ICU 2) 
12 patients. In total, ICU 1 treated 39 COVID-19 patients 
(661 patient days). ICU 2 treated 14 COVID-19 patients 
(209 patient days). No institutional review board (IRB) 
approval was required as this study did not involve any 
patients.
ICU cleaning/disinfection
After the first COVID-19 wave, both subunits were 
cleaned in order to provide care for non-COVID-19 
patients. All surfaces, devices and floors in ICU 1 were 
disinfected by nurses and cleaning staff with aldehyde-
based  Kohrsolin® 1% (Wilbert Hygiene, Germany). In 
addition, a dry mist hydrogen peroxide  (H2O2) nebulisa-
tion technique (Dosymist XL, SolidFog  Technologies®, 
Belgium and  H2O2 à 12% Fisher  Scientific
®, USA) was 
used in ICU 1 in the ICU pharmacy room. The purpose 
to use this relatively novel technique in the present study 
was to gain more experience with it and to test it in a 
small, designated area. With the aid of the hydrogen per-
oxide technology, a dry aerosol is generated, with the oxi-
dative action of hydroxyl radicals leading to antimicrobial 
properties. Quality control of the  H2O2 disinfection was 
performed with chemical indicators (3M  Healthcare®, 
USA) [successful decontamination indicated by color 
change on test kit] and biological indicators (Geobacillus 
stearothermophilus,  Crosstex®, USA) [successful decon-
tamination indicated by 6-log reduction between posi-
tive and negative control]. Surfaces, devices and floors 
in ICU 2 were disinfected by nurses and cleaning staff 
with  Kohrsolin® 1% (Wilbert Hygiene, Germany) only. 
To minimize biases, nurses and cleaning staff were not 
aware that this study would be conducted in both ICUs. 
Cleaning and disinfection were not supervised by the 
study team.
Virus sampling and analysis
After the cleaning procedures, 86 viral swabs (FLO-
QSwabs, UTM-RT transport medium,  Copan®, Italy) 
were taken from different locations in both ICUs (rep-
resenting high-frequency touch surfaces, patient-sur-
rounding areas, healthcare-worker changing areas and 
sinks including siphons) with a minimal swabbing sur-
face dimension of 10 × 10 cm. Sampling objects were 30 
monitors/keyboards (bedside), 8 tabletops to prepare 
drugs for application including adjacent sinks, 17 indi-
vidual sinks including siphons in patient rooms, 6 floors 
of patient compartments and 1 main exit gate (floor), 13 
respirator touch screens and handling buttons, 2 phy-
sician’s work desks, 2 non-personalised telephones, 2 
perfusors, 4 rolling trolleys/tables, 2 fridge doors in the 
ICU pharmacy, 1 chair and 2 surfaces in kitchens. Due to 
the different configurations and designs of the two ICU 
subunits, it was not possible to take an equal amount of 
swabs from both ICU subunits. Figure  1 demonstrates 
both ICU subunits and sampling points are indicated.
The swabbed area was individualised according to the 
swabbed object size and shape. Real-time reverse tran-
scriptase polymerase chain reaction (rtPCR) was per-
formed to detect SARS-CoV-2 RNA with inclusion of 
positive and negative control. PCR conditions were as 
previously described by Corman et al. [9].
Bacterial sampling, culture, identification and resistance 
testing
In parallel to the viral sampling, a total of 90 moistured 
swabs (eSwabs™,  Copan®, Italy, comprising 1 millilitre of 
Amies medium) were taken from the same locations in 
both ICUs, analogous to the viral sampling (Fig. 1).
Dependent on the object size and shape, the swabbed 
area was individualised. In general, the largest possible 
area to swab was chosen.
All swabs were plated on 5% sheep blood agar and 
MacConkey agar plates in three fractions. Subsequently, 
the samples were incubated for 48 h at 37 °C in ambient 
air. After incubation, colony forming units (CFU) were 
analysed semiquantitatively. Growth in the first fraction 
of the agar plate corresponded to  103–104 CFU/ml, in the 
first and second fraction to  104–105  CFU/ml and in all 
three fractions to  105–106 CFU/ml.
Subcultures were plated on 5% sheep blood agar or 
MacConkey agar and identification was done as previ-
ously described [10] with the exception that identification 
was done using both a BD Phoenix™, Becton Dickinson, 
USA, automated identification and susceptibility testing 
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Fig. 1 Both ICU subunits with indicated sampling points. a represents ICU 1, b represents ICU 2
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system as well as a Bruker MALDI-TOF–MS biotyper 
(Bruker, Germany). Susceptibility testing was done using 
the BD Phoenix system.
Results
All of the 86 viral swabs sampled tested negative for 
SARS-CoV-2 RNA. Two samples from ICU 1 (sink in 
the pharmacy and one monitor/keyboard) were initially 
weakly positive but inconclusive. The quantification cycle 
values for those two swabs were 43.17 and 38.94 respec-
tively. However, this finding could not be reproduced in a 
subsequent confirmatory test.
All chemical and biological indicators demonstrated 
successful (bacterial) decontamination of the ICU 1 phar-
macy room. Tables 1 and 2 summarise cultivated bacteria 
on different surfaces of both subunits of the ICU after 
disinfection. In ICU 1, most bacteria were found in the 
sinks and associated siphons—in the individual sinks in 
Table 1 Bacterial contamination on  ICU 1 according to  swabbed objects and  swab count. Numbers in  () indicating 




Pseudomonas spp. Other detected bacteria
Bacterial contamination ICU 1
Monitors/keyboards 18 Coagulase-negative staphylococci  103–104/ml (10/18)
Tabletops, sinks and siphons in 
drug preparation areas
5 Pseudomonas aeruginosa 
 105–106/ml (2/5), Pseu-
domonas putida  105–106/
ml (1/5)
Stenotrophomonas maltophilia  105–106/ml (3/5), 
Enterobacter cloacae  105–106/ml (1/5), coagulase-
negative staphylococci  103–104/ml (1/5)
Individual sinks in patient area 12 Pseudomonas aeruginosa 
 105–106/ml (2/12), Pseu-
domonas spp.  103–104/ml 
(1/12)
Klebsiella oxytoca  104–105/ml (1/12), Stenotropho-
monas maltophilia  105–106/ml (1/12), coagulase-
negative staphylococci  103–104/ml (1/12)
Floors in patient compartment 6 Coagulase-negative staphylococci  103–104/ml (3/6)
Respirators 13 Coagulase-negative staphylococci  103–104/ml (1/13)
Work desk physicians 2 Coagulase-negative staphylococci  103–104/ml (2/2)
Telephones non-personalized 2 Coagulase-negative staphylococci  103–104/ml (1/2)
Perfusors 2
Rolling trolleys/tables 4 Coagulase-negative staphylococci  103–104/ml (2/4)
Fridges pharmacy 2
Chair 1
Table 2 Bacterial contamination on  ICU 2 according to  swabbed objects and  swab count. Numbers in  () indicating 




Pseudomonas spp. Other detected bacteria
Bacterial contamination ICU 2
Monitors/keyboards 12 Enterococcus faecium  103–104/ml (2/12), 
coagulase-negative staphylococci 
 103–104/ml (8/12)
Tabletops, sinks and siphons in 
drug preparation areas
3 Coagulase-negative staphylococci  103–104/
ml (3/3)
Individual sinks in patient area 5 Pseudomonas aeruginosa  104–105/ml (1/5), 
Pseudomonas putida  104–105/ml (1/5), 
Pseudomonas spp.  104–105/ml (2/5)
Achromobacter  103–104/ml (1/5), Steno-
trophomonas maltophilia  104–105/ml 
(1/5), coagulase-negative staphylococci 
 104–105/ml (2/5)
Floor main exit gate 1 Coagulase-negative staphylococci  103–104/
ml (1/1)
Surface patient kitchen 2 Coagulase-negative staphylococci  103–104/
ml (1/2)
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patient rooms and at tabletops employed for drug prep-
aration by health care staffing (Table  1). Pseudomonas 
aeruginosa, Pseudomonas putida, Stenotrophomonas 
maltophilia, Klebsiella oxytoca and Enterobacter cloacae 
were cultured from these areas. In line with ICU 1, Pseu-
domonas aeruginosa, Pseudomonas putida, Stenotropho-
monas maltophilia and Achromobacter spp. were found 
in ICU 2 in the sinks (Table  2). No multidrug-resistant 
(MDR) P. aeruginosa was detected.
Enterococcus faecium was cultivated in two out of 12 
swabs from monitors/keyboards. In both ICUs, coagu-
lase-negative Staphylococci were found in most swabbed 
areas but with low CFU numbers (mostly  103–104 per ml 
corresponding to less than 5 CFU/cm2) (Tables 1 and 2).
Discussion
The aim of this study was to investigate the persistence of 
SARS-CoV-2 and bacteria on different devices and sur-
faces after disinfecting measures in two tertiary care ICU 
subunits that had exclusively treated COVID-19 patients. 
The main finding of this study is that no SARS-CoV-2 
RNA was detected by rtPCR. However, pathogenic bac-
teria were abounded mainly in sinks and corresponding 
siphons of the ICUs and enterococci were isolated from 
two monitors. Gram-positive bacteria were mainly iso-
lated from surfaces (e.g. monitors/keyboards) whereas 
Gram-negative bacteria were mainly detected in plumb-
ing units.
To date, it has not been clearly established how long 
and to what extent SARS-CoV-2 RNA contaminates envi-
ronmental surfaces and devices in hospitals. A recent 
study has described a low percentage of positive samples 
in an emergency room and the sub-intensive care ward 
[11]. In another study, almost 57% of rooms treating 
COVID-19 patients had at least one environmental sur-
face contaminated [12].
In our study, viral RNA was not detectable on any of 
the swabbed locations of the two ICU subunits, which 
suggests that conventional disinfection measures are 
likely sufficient to prevent further spread of the virus. 
This finding thus might contribute to infection and pre-
vention policies.
Already back in 1974, The Lancet published an arti-
cle describing isolation of Pseudomonas aeruginosa 
in hospital sinks [13]. Since then, various studies have 
investigated hospital water supply systems as potential 
reservoirs for the transmission of pathogenic bacteria in 
hospitals [14–18].
In line with previous studies [15, 16, 18], we found 
Pseudomonas aeruginosa in sinks/siphons in both ICUs. 
Specifically regarding the ICU setting, Zhou et al. dem-
onstrated that sink traps may act as an important source 
of Pseudomonas spp. leading to colonisation or infection 
of critically ill patients [18]. Additionally, stagnant water 
in general bears a risk for being a reservoir and source of 
outbreaks with several pathogens [19]. This finding high-
lights the need for constant awareness of possible bacte-
rial reservoirs and the need for further refining cleaning 
methods in the ICU.
In this line of research it has been suggested that 
devices applying heat and electromechanical vibration to 
siphons lead to lower colonisation of patients with mul-
tidrug-resistant (MDR) Pseudomonas spp. [16] and that 
self-disinfecting sinks reduced Pseudomonas spp. biobur-
den in a pediatric ICU [20], offering possibilities to lower 
transmission of MDR pathogens. Whether such meas-
ures prove feasible and effective in other ICU settings 
remains to be elucidated in further studies and is beyond 
the scope of this study. However, no MDR Pseudomonas 
aeruginosa was detected in our ICUs despite the fact that 
several patients in the ICU had been colonised with MDR 
Pseudomonas aeruginosa.
Other cultured bacteria associated with moist environ-
ments were Stenotrophomonas maltophilia, Klebsiella 
oxytoca and Achromobacter spp., all Gram-negative, 
potentially harmful bacteria. Stenotrophomonas malt-
ophilia is known to cause hospital-acquired infections 
and is associated with multidrug resistance [21, 22]. 
Klebsiella spp. can be responsible for infectious compli-
cations, especially hospital-acquired pneumonias, uri-
nary tract infections or septicemias [23]. Furthermore, 
Achromobacter spp. have been linked to increased risk 
of morbidity and mortality in critically ill patients in a 
study reporting a 18  month lasting epidemic in an ICU 
[24]. Additionally, Enterobacter cloacae was cultured 
from sinks located next to tabletops employed for drug 
preparation in ICU 1. Enterobacterales (especially car-
bapenem-resistant strains) are an important cause of 
healthcare-associated infections and transmission by 
means of environmental reservoirs, such as therapeu-
tic beds, has been described [25, 26]. The colonisation 
of critically ill patients with carbapenemase-producing 
Enterobacterales has been associated with an increased 
length of stay, as well as with a 1.8 higher death hazard 
ratio as opposed to non-colonised ICU patients [27].
Such findings mandate thorough disinfection of ICUs 
and surveillance of sinks and siphons as a source for fur-
ther outbreaks. Water-free ICUs might reduce the risk of 
nosocomial transmission from bacteria residing in sinks 
and siphons [28].
Monitors and keyboards are frequently used devices 
in the everyday care in the ICU. We found Enterococcus 
faecium on two out of 12 monitors/keyboards in ICU 2, 
a pathogen known to cause hospital-acquired infections 
and possibly exhibiting complex resistance patterns, e.g. 
vancomycin-resistant strains. The failure of disinfection 
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in this case is most likely because of the applied manual 
disinfection, which is prone to failure. However, we were 
not able to assess the individual cleaning performance. In 
a large multicenter, randomised trial, a cleaning bundle 
(REACH) showed promising results in reducing espe-
cially enterococcal infections [29]. The implementation of 
such bundles in ICUs might probably lead to less noso-
comial infections in critically ill patients and warrants 
investigation in further trials.
Coagulase-negative staphylococci were detected in the 
majority of the swabbed locations. These bacteria are 
known to be associated with human skin and mucosa 
and can be a source for infections of foreign bodies or 
indwelling catheters [30]. It remains speculative, whether 
the finding of these bacteria in the disinfected ICUs has 
a clinical relevance with regard to the transmission of 
potentially harmful infections.
The use of the hydrogen peroxide nebulisation tech-
nique has been shown to reduce bacterial burden on 
medical devices [31]. In the present study, we did not 
analyse the effectiveness of this technique as compared 
to control locations without its use. However, we were 
not able to culture bacteria in the areas where hydrogen 
peroxide nebulisation was used. This supports the possi-
ble role of hydrogen peroxide as a useful adjunct for ICU 
disinfection. Another advantage of this technique is the 
operator-independence.
Strengths of this study are the structured and com-
prehensive viral/bacterial sampling of different objects 
and its pragmatic design during COVID-19 pandemics 
reflecting everyday situations in ICUs with possibly rel-
evant impacts on patient outcomes. Furthermore, the 
single-blinded study design ensured the investigation of 
regular cleaning quality.
Our study has several limitations. First, the ICUs were 
cleaned and disinfected by numerous employees of the 
ICU department and facility management. As a conse-
quence, different parts of the facilities were probably not 
cleaned uniformly or in the same intensity. However, this 
fact reflects daily real-life work processes in hospitals. 
Second, the investigators could not verify if the objects 
actually had been cleaned or had been omitted owing to 
human factors such as overlooking or ignoring.
Third, the analysed objects differed in shape and size, 
which might have influenced the swabbing technique. 
Fourth, no cluster-randomisation could be performed 
between the two ICU subunits due to time-constraints 
and urgent demand for ICU beds. Finally, due to the 
dynamic of the pandemic in our hospital, both ICUs were 
not swabbed and tested as a baseline prior to cleaning 
and disinfection and the timing of the swabbing was not 
randomly performed. This should be taken into account 
in future studies with a similar design.
Conclusion
In conclusion, several bacteria possibly leading to colo-
nisation or infections of critically ill patients were cul-
tured from swabs taken from disinfected ICUs after 
the COVID-19 pandemic. SARS-CoV-2 RNA was not 
detected on any of the swabbed objects further sup-
porting that conventional disinfection is sufficient to 
safely repurpose COVID-19 ICUs to routine ICUs 
despite the contagious nature of the disease.
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